Compare ITT & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITT | BAX |
|---|---|---|
| Founded | 1920 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 9.4B |
| IPO Year | N/A | N/A |
| Metric | ITT | BAX |
|---|---|---|
| Price | $181.17 | $18.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 10 |
| Target Price | ★ $201.11 | $25.67 |
| AVG Volume (30 Days) | 592.3K | ★ 8.3M |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | ★ 0.78% | 0.22% |
| EPS Growth | ★ 2.16 | N/A |
| EPS | ★ 5.99 | N/A |
| Revenue | $3,813,500,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $7.91 | $5.20 |
| Revenue Next Year | $5.90 | $2.02 |
| P/E Ratio | $30.21 | ★ N/A |
| Revenue Growth | ★ 8.01 | 3.90 |
| 52 Week Low | $105.64 | $17.40 |
| 52 Week High | $197.07 | $37.74 |
| Indicator | ITT | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 47.61 | 43.20 |
| Support Level | $177.48 | $18.33 |
| Resistance Level | $183.44 | $19.17 |
| Average True Range (ATR) | 5.03 | 0.54 |
| MACD | -0.46 | 0.21 |
| Stochastic Oscillator | 53.79 | 63.23 |
ITT began its journey as International Telephone & Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.